Annual Operating Expenses
$34.56 M
-$19.28 M-35.81%
December 31, 2023
Summary
- As of February 12, 2025, MREO annual total operating expenses is $34.56 million, with the most recent change of -$19.28 million (-35.81%) on December 31, 2023.
- During the last 3 years, MREO annual operating expenses has fallen by -$16.64 million (-32.50%).
- MREO annual operating expenses is now -35.81% below its all-time high of $53.84 million, reached on December 31, 2022.
Performance
MREO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$9.15 M
-$3.30 M-26.50%
September 30, 2024
Summary
- As of February 12, 2025, MREO quarterly total operating expenses is $9.15 million, with the most recent change of -$3.30 million (-26.50%) on September 30, 2024.
- Over the past year, MREO quarterly operating expenses has dropped by -$3.30 million (-26.50%).
- MREO quarterly operating expenses is now -26.50% below its all-time high of $12.45 million, reached on June 30, 2024.
Performance
MREO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
MREO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.8% | -26.5% |
| 3 y3 years | -32.5% | - |
| 5 y5 years | -21.0% | - |
MREO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.8% | at low | -26.5% | +58.8% |
| 5 y | 5-year | -35.8% | at low | -26.5% | +58.8% |
| alltime | all time | -35.8% | +141.1% | -26.5% | +58.8% |
Mereo BioPharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $9.15 M(-26.5%) |
| Jun 2024 | - | $12.45 M(+32.1%) |
| Mar 2024 | - | $9.42 M(+13.2%) |
| Dec 2023 | $34.56 M(-35.8%) | $8.32 M(-9.7%) |
| Sep 2023 | - | $9.22 M(+60.1%) |
| Jun 2023 | - | $5.76 M(-48.8%) |
| Mar 2023 | - | $11.26 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $53.84 M(+1.0%) | - |
| Dec 2021 | $53.30 M(+4.1%) | - |
| Dec 2020 | $51.20 M(-1.2%) | - |
| Dec 2019 | $51.81 M(+18.4%) | - |
| Dec 2018 | $43.75 M(+202.6%) | - |
| Dec 2017 | $14.46 M(+0.9%) | - |
| Dec 2016 | $14.33 M | - |
FAQ
- What is Mereo BioPharma annual total operating expenses?
- What is the all time high annual operating expenses for Mereo BioPharma?
- What is Mereo BioPharma annual operating expenses year-on-year change?
- What is Mereo BioPharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Mereo BioPharma?
- What is Mereo BioPharma quarterly operating expenses year-on-year change?
What is Mereo BioPharma annual total operating expenses?
The current annual operating expenses of MREO is $34.56 M
What is the all time high annual operating expenses for Mereo BioPharma?
Mereo BioPharma all-time high annual total operating expenses is $53.84 M
What is Mereo BioPharma annual operating expenses year-on-year change?
Over the past year, MREO annual total operating expenses has changed by -$19.28 M (-35.81%)
What is Mereo BioPharma quarterly total operating expenses?
The current quarterly operating expenses of MREO is $9.15 M
What is the all time high quarterly operating expenses for Mereo BioPharma?
Mereo BioPharma all-time high quarterly total operating expenses is $12.45 M
What is Mereo BioPharma quarterly operating expenses year-on-year change?
Over the past year, MREO quarterly total operating expenses has changed by -$3.30 M (-26.50%)